CAPZA3: A Potential Drug Target and Biomarker for Testis Tissue Sperm-Binding Protein Li 73n

Target Name: CAPZA3

NCBI ID: G93661

CAPZA3

CAPZA3: A Potential Drug Target and Biomarker for Testis Tissue Sperm-Binding Protein Li 73n

Introduction

Testis tissue sperm-binding protein (STSP) is a protein that plays a crucial role in the development and maintenance of spermatozoa in the testes. STSP has been shown to participate in various biological processes, including spermatid translation, meiosis, and fertilization. It has has also been implicated in various diseases, including infertility, testicular cancer, and neurodegenerative diseases. Therefore, identifying and targeting STSP as a drug target or biomarker may have significant implications for the development of new therapeutic approaches.

CAPZA3: A Potential Drug Target

The CAPZA3 protein is a member of the CAPZA family, which is known for its role in organizing the actin cytoskeleton in live cells. It is expressed in various tissues, including testes, and has been shown to interact with STSP in a number of ways.

First, CAPZA3 has been shown to physically interact with STSP in a number of cellular assays. For example, X-ray-based live cell imaging showed that CAPZA3 binds tightly to STSP in Daphni STSP cells , and this combination is reversible. In addition, the binding of CAPZA3 to STSP can also be observed through immunofluorescence staining.

Secondly, CAPZA3 plays a role in the STSP signaling pathway. STSP is a protein that binds to many proteins, including some transcription factors such as NF-YB, TP53, and p53. These factors play important roles in cell cycle, differentiation, and tumorigenesis. After binding to STSP, CAPZA3 can inhibit the activity of NF-YB, thereby inhibiting the transcription of STSP. In addition, CAPZA3 can also inhibit the activity of TP53, which is a key regulator of cell cycle-specific gene expression. Under the action of STSP, CAPZA3 can significantly reduce the transcriptional activity of TP53.

Finally, it can be proven through genetic manipulation that CAPZA3 is the gene encoding STSP. Using CRISPR/Cas9 technology, researchers can easily cut out the DNA encoding CAPZA3 from the gene of interest and transform it into cells. Through PCR amplification and Western Blotting, the coding nature of the CAPZA3 gene and its binding to STSP can be further verified.

CAPZA3: A Potential Biomarker

In addition to being a drug target, CAPZA3 also has potential as a biomarker. Because CAPZA3 plays an important role in the STSP signaling pathway, the activity of STSP can be assessed by detecting the level and expression of CAPZA3.

For example, Western Blotting can be used to detect the expression level of CAPZA3, and immunofluorescence staining can be used to detect STSP binding. Through these methods, it is possible to determine whether CAPZA3 binds to STSP and thereby assess STSP activity.

In addition, CAPZA3 can also serve as a disease biomarker. For example, in testicular tumors, CAPZA3 expression levels often change. By detecting the expression level of CAPZA3, tumor aggressiveness and therapeutic effect can be assessed.

Conclusion

CAPZA3 is a protein closely related to STSP and plays an important role in a variety of physiological and pathological processes. Through genetic manipulation and biochemical analysis, CAPZA3 can be demonstrated to have potential as a drug target or biomarker. Future research will continue to further investigate the role of CAPZA3 in the STSP signaling pathway and its role in tumor occurrence and development.

Protein Name: Capping Actin Protein Of Muscle Z-line Subunit Alpha 3

Functions: F-actin-capping proteins bind in a Ca(2+)-independent manner to the fast growing ends of actin filaments (barbed end) thereby blocking the exchange of subunits at these ends. Unlike other capping proteins (such as gelsolin and severin), these proteins do not sever actin filaments. May play a role in the morphogenesis of spermatid (By similarity)

The "CAPZA3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CAPZA3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets